Abstract: Described examples include an apparatus includes a dichroic wedge and a spatial light modulator optically coupled to the dichroic wedge. The apparatus also includes a display optically coupled to the spatial light modulator. The display includes a waveguide having a first side and a second side and a first diffractive optical element on the first side of the waveguide. The display also includes a second diffractive optical element on the first side of the waveguide and a third diffractive optical element on the second side of the waveguide.

Abstract: Examples of the present disclosure describe systems and methods for malicious software detection based on API trust. In an example, a set of software instructions executed by a computing device may call an API. A hook may be generated on the API, such that a threat processor may receive an indication when the API is called. Accordingly, the threat processor may generate a trust metric based on the execution of the set of software instructions, which may be used to determine whether the set of software instructions poses a potential threat. For example, one or more call stack frames may be evaluated to determine whether a return address is preceded by a call instruction, whether the return address is associated with a set of software instructions or memory associated with a set of software instructions, and/or whether the set of software instructions satisfies a variety of security criteria.

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6, 7-dihydro-7, 14-methanobenzimidazo[1, 2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: The present disclosure provides methods of combining methanotrophic bacterial biomass production with a methanation process, comprising: (a) culturing a methanotrophic bacterium in the presence of methane and oxygen to produce biomass and carbon dioxide; and (b) generating methane using the carbon dioxide produced in step (a) and hydrogen. Also provided are systems that comprise: (a) one or more bioreactors comprising a culture of a methanotrophic bacterium to produce biomass and carbon dioxide in the presence of methane, and (b) one or more reactors for generating methane, wherein the system is configured so that the carbon dioxide generated from reactor (a) is fed into reactor (b).

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: In various embodiments, methods and systems, for automatically generating guides, are provided. A user can generate guides based on content zones of a wireframe layout or visual element layout. A selection of a content zone having a shape is received. A selection of a guide creation action to generate a grid structure encompassing the shape of the content zone is received. A determination of a boundary set for the shape is made. The boundary set includes a top boundary, a bottom boundary, a left boundary, and a right boundary. The boundary set is based on a data (e.g., vector, pixel, text) perimeter of the shape. The grid structure is automatically generated based on the shape. The grid structure comprises a top horizontal guide, a bottom horizontal guide, a left vertical guide, and right vertical guide. The grid structure is located adjacent to portions of the boundary set of the shape.

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: Two-sided and two-sided mirrored fire barriers having each of their two sides tested, rated, and certified for use in common spaces, such as spaces shared between two rooms are taught. Two-sided barriers require only one barrier and one installation, instead of the two presently needed. Two-sided barriers may have different construction and composition on each side; whereas each side of a mirrored fire barrier is a mirror image of the other. All two-sided barriers include top-mounted, bottom-mounted, and side-mounted barriers, gas and moisture impermeable barriers, and barriers shaped to fit into the expansion joint spaces created when a plurality of expansion joints intersect. The barriers are disposed to various sizes, lengths, widths, and depths, in addition to variations in shape, content, number and composition of layers, materials, and attachment means required to accommodate the variety of sizes and shapes of expansion-joint spaces and the desired rating, in terms of hours.

Abstract: A series of substituted benzimidazole, imidazo[1,2-?]pyridine and pyrazolo[1,5-?]pyridine derivatives, and analogs thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

Abstract: Various fenofibrate dosage forms contain a plurality of beads or particles, where the beads or particles include a pharmaceutical composition comprising fenofibrate; from 0.3% to 10% by weight of the beads or particles of a surfactant; and from about 5% to about 15% by weight of the beads or particles of a water soluble or water dispersible cellulosic binder. The mass ratio of the drug to the binder in the dosage form is between about 3.5:1 and 4.5:1; and the dosage form produces a first Cmax in vivo that is between about 10% and about 50% higher than a comparative Cmax produced by a comparative dosage form. The comparative dosage form comprises the drug and the binder in a ratio of between about 5:1 and 15:1. The dosage form may contain a plurality of beads or particles, each of the beads or particles including a pharmaceutical composition containing from about 20% to about 55% by weight of fenofibrate; from 0.

Abstract: A series of substituted benzimidazole, imidazo[1,2-a]pyridine and pyrazolo[1,5-a]pyridine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

Abstract: A fire barrier assembly includes a fire barrier, mounting elements and securement elements. The mounting elements are positioned along the length of the fire barrier on an inner surface of the fire barrier. The mounting elements engage one or more of the securement elements to the fire barrier. When installed within an expansions space, the securement elements are used to tension mount the fire barrier assembly securely and generally immovably within the expansion space, without the need for any mechanical, adhesive, or other fixed connection to anchor the fire barrier assembly in place. As such, no modification to the building structures defining the expansion space (e.g. no drilling holes, applying adhesive, etc.) is need to mount the fire barrier assembly. If desired, the fire barrier assembly may easily be detached and removed from the expansion space.

Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.

Abstract: A series of substituted benzimidazole, imidazo[1,2-?]pyridine and pyrazolo[1,5-?]pyridine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

Abstract: In various embodiments, methods and systems, for automatically generating guides, are provided. A user can generate guides based on content zones of a wireframe layout or visual element layout. A selection of a content zone having a shape is received. A selection of a guide creation action to generate a grid structure encompassing the shape of the content zone is received. A determination of a boundary set for the shape is made. The boundary set includes a top boundary, a bottom boundary, a left boundary, and a right boundary. The boundary set is based on a data (e.g., vector, pixel, text) perimeter of the shape. The grid structure is automatically generated based on the shape. The grid structure comprises a top horizontal guide, a bottom horizontal guide, a left vertical guide, and right vertical guide. The grid structure is located adjacent to portions of the boundary set of the shape.